NCT06264557

Cognitive Therapy Software for Improving Cognitive Function for Patients With Mild Cognitive Impairment

A Multicenter, Prospective, Comparative, Randomized, Independent Rater-blind, Superiority Clinical Trial to Compare the Safety and Efficacy of the Cognitive Therapy Software 'SUPERBRAIN DEX' With a Control Group for Patients With MCI

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 140 (actual)
• Sponsor: Rowan · Industry
• Sex: All
• Age: 50 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Cognitive therapy software for improving cognitive function for patients with mild cognitive impairment

Detailed description

A multicenter, prospective, comparative, randomized, independent rater-blind, superiority, pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software 'SUPERBRAIN DEX' for improving cognitive function with a control group for patients with mild cognitive impairment

Conditions

• Mild Cognitive Impairment
• MCI

Interventions

Type	Name	Description
DEVICE	SB-100	Cognitive training will be conducted once a day, and it will take 15 to 30 minutes. It consists of cognitive training and educational videos.
OTHER	Educational book	Book of education on daily rules for preventing dementia

Timeline

• Start date: 2024-01-15
• Primary completion: 2025-03-13
• Completion: 2025-06-02
• First posted: 2024-02-20
• Last updated: 2025-10-02

Locations

12 sites across 1 country: South Korea